Drugs / NNC0143-0406
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02938572 | Oct 2016 → Jun 2017 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 1 | NCT02612844 | Nov 2015 → Jun 2016 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC0143-0406 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02938572 ↗ |
| Route | Subcutaneous | “Administered subcutaneously (s.c. under the skin)” NCT02938572 ↗ |